Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurren
Short Description: Onc dx head/neck t3-4 noprog
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2006
Effective Date: January 1, 2007
Termination Date: